News Update April 6, 2018
Mark McClellan, MD, PhD, Comments on FDA Public Health Initiatives
Read more in USA Today.
Read MoreNews Update April 6, 2018
The Evolving Pharmaceutical Benefits Market
Pharmaceutical benefit managers (PBMs), a once obscure segment of the health care financing...
Read MoreNews Update April 3, 2018
Initial Analysis of 2018 Enrollment in Health Insurance Exchanges
On the Health Affairs blog, David Anderson offers his Initial Analysis Of 2018 Enrollment By CSR...
Read MoreNews Update March 30, 2018
When does the cost of care become toxic?
Can the cost of health care be bad for you? In the January/February issue of the North Carolina...
Read MoreNews Update March 29, 2018
How RWE Is Becoming the Real Deal
The randomized controlled trial reigns supreme, but the FDA is working on ways to incorporate...
Read More
News Update March 26, 2018
A Framework For Evaluating Medicaid Buy-In Proposals
Read more from David Anderson and Emma Sandoe on the Health Affairs blog.
Read More